Finance

Lists
Why is FUM up 5,50%?
Dive Deeper
FUM:LON
Futura Medical PLC
GBX 0,23
+5,50%
(+0,012) 1D
13 āš•.āšĨ., 16 āŧ‚āšĄāš‡ 35 āš™āšēāš—āšĩ 28 āš§āšīāš™āšēāš—āšĩ GMT+1  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for FUM...
Open
GBX 0,21
High
GBX 0,23
Low
GBX 0,21
Mkt. cap
3,38 āšĨāŧ‰āšēāš™
Avg. vol.
13,22 āšĨāŧ‰āšēāš™
Volume
605,27Â āšžāšąāš™
52-wk high
GBX 3,21
52-wk low
GBX 0,18
EPS
GBX-0,01
Shares outstanding
1,48Â āš•āš·āŧ‰
No. of employees
13
Open
GBX 0,21
High
GBX 0,23
Low
GBX 0,21
Mkt. cap
3,38 āšĨāŧ‰āšēāš™
Avg. vol.
13,22 āšĨāŧ‰āšēāš™
Volume
605,27Â āšžāšąāš™
52-wk high
GBX 3,21
52-wk low
GBX 0,18
EPS
GBX-0,01
Shares outstanding
1,48Â āš•āš·āŧ‰
No. of employees
13
News stories
From web sources and news partners
Kalkine Media
Kalkine Media
·
13 āšŠāšŧāŧˆāš§āŧ‚āšĄāš‡āšāŧˆāš­āš™
Futura Medical (AIM:FUM): Does A Finance Reshuffle And New Eroxon Intense Data Shape Its Formal Sale Process?
About Futura Medical PLC
CEOJames Henry Barder
Employees13
Founded2001
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in GBP
Loading Previous Earnings...
Revenue
Net income
All values in GBP
āš.āš. 2025
āš—.āš§. 2025
āšĄ.āš™. 2026
āšĄāšī.āš–. 2026
Revenue
347,75Â āšžāšąāš™
347,75Â āšžāšąāš™
810,76Â āšžāšąāš™
810,76Â āšžāšąāš™
Cost of goods sold
-150,66Â āšžāšąāš™
-150,66Â āšžāšąāš™
58,00
58,00
Cost of revenue
-150,66Â āšžāšąāš™
-150,66Â āšžāšąāš™
58,00
58,00
Research and development expenses
553,14Â āšžāšąāš™
553,14Â āšžāšąāš™
364,93Â āšžāšąāš™
364,93Â āšžāšąāš™
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,27 āšĨāŧ‰āšēāš™
1,27 āšĨāŧ‰āšēāš™
1,09 āšĨāŧ‰āšēāš™
1,09 āšĨāŧ‰āšēāš™
Operating expense
1,69 āšĨāŧ‰āšēāš™
1,69 āšĨāŧ‰āšēāš™
1,41 āšĨāŧ‰āšēāš™
1,41 āšĨāŧ‰āšēāš™
Total operating expenses
1,54 āšĨāŧ‰āšēāš™
1,54 āšĨāŧ‰āšēāš™
1,41 āšĨāŧ‰āšēāš™
1,41 āšĨāŧ‰āšēāš™
Operating income
-1,19 āšĨāŧ‰āšēāš™
-1,19 āšĨāŧ‰āšēāš™
-598,18Â āšžāšąāš™
-598,18Â āšžāšąāš™
Other non operating income
-
-
-
-
EBT including unusual items
-1,19 āšĨāŧ‰āšēāš™
-1,19 āšĨāŧ‰āšēāš™
-590,58Â āšžāšąāš™
-590,58Â āšžāšąāš™
EBT excluding unusual items
-1,19 āšĨāŧ‰āšēāš™
-1,19 āšĨāŧ‰āšēāš™
-590,58Â āšžāšąāš™
-590,58Â āšžāšąāš™
Income tax expense
50,00Â āšžāšąāš™
50,00Â āšžāšąāš™
-
-
Effective tax rate
-4,19%
-4,19%
-
-
Other operating expenses
-127,50Â āšžāšąāš™
-127,50Â āšžāšąāš™
-50,00Â āšžāšąāš™
-50,00Â āšžāšąāš™
Net income
-1,24 āšĨāŧ‰āšēāš™
-1,24 āšĨāŧ‰āšēāš™
-590,58Â āšžāšąāš™
-590,58Â āšžāšąāš™
Net profit margin
-357,26%
-357,26%
-72,84%
-72,84%
Earnings per share
-
-
-
-
Interest and investment income
-
-
7,61Â āšžāšąāš™
7,61Â āšžāšąāš™
Interest expense
-
-
-
-
Net interest expenses
-
-
7,61Â āšžāšąāš™
7,61Â āšžāšąāš™
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,16 āšĨāŧ‰āšēāš™
-1,16 āšĨāŧ‰āšēāš™
-570,23Â āšžāšąāš™
-570,23Â āšžāšąāš™
Gain or loss from assets sale
44,00
44,00
-
-
AI content may include mistakes. Learn more
āŧāš­āšąāššāš‚āš­āš‡ Google